S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Owens & Minor (OMI) Competitors

$24.64
+0.31 (+1.27%)
(As of 03/1/2024 ET)

OMI vs. PDCO, HRMY, MORF, INBX, MYGN, INMD, AGIO, SANA, RCUS, and EYE

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), Harmony Biosciences (HRMY), Morphic (MORF), Inhibrx (INBX), Myriad Genetics (MYGN), InMode (INMD), Agios Pharmaceuticals (AGIO), Sana Biotechnology (SANA), Arcus Biosciences (RCUS), and National Vision (EYE). These companies are all part of the "medical" sector.

Owens & Minor vs.

Patterson Companies (NASDAQ:PDCO) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking.

Patterson Companies has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.47B0.38$207.56M$2.0313.47
Owens & Minor$10.33B0.18-$41.30M-$0.54-45.63

Patterson Companies received 110 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.56% of users gave Patterson Companies an outperform vote while only 49.02% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
359
52.56%
Underperform Votes
324
47.44%
Owens & MinorOutperform Votes
249
49.02%
Underperform Votes
259
50.98%

Patterson Companies currently has a consensus price target of $33.50, indicating a potential upside of 22.49%. Owens & Minor has a consensus price target of $22.29, indicating a potential downside of 9.55%. Given Owens & Minor's stronger consensus rating and higher possible upside, analysts clearly believe Patterson Companies is more favorable than Owens & Minor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Owens & Minor
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Patterson Companies has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.

79.2% of Patterson Companies shares are held by institutional investors. Comparatively, 98.0% of Owens & Minor shares are held by institutional investors. 1.5% of Patterson Companies shares are held by insiders. Comparatively, 3.6% of Owens & Minor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Patterson Companies has a net margin of 2.95% compared to Patterson Companies' net margin of -0.40%. Owens & Minor's return on equity of 20.98% beat Patterson Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies2.95% 20.98% 7.70%
Owens & Minor -0.40%11.62%2.03%

In the previous week, Patterson Companies had 39 more articles in the media than Owens & Minor. MarketBeat recorded 59 mentions for Patterson Companies and 20 mentions for Owens & Minor. Patterson Companies' average media sentiment score of 0.86 beat Owens & Minor's score of 0.16 indicating that Owens & Minor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
8 Very Positive mention(s)
7 Positive mention(s)
22 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owens & Minor
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Patterson Companies beats Owens & Minor on 14 of the 18 factors compared between the two stocks.


Get Owens & Minor News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.89B$8.79B$5.10B$17.63B
Dividend YieldN/A2.18%2.83%3.55%
P/E Ratio-45.6320.35186.6723.03
Price / Sales0.181.323,061.166.78
Price / Cash4.8012.44100.9318.47
Price / Book2.042.624.535.86
Net Income-$41.30M$273.67M$115.01M$863.03M
7 Day Performance3.18%-0.54%5.72%1.63%
1 Month Performance25.27%8.63%12.82%3.14%
1 Year Performance45.80%23.18%12.95%94.49%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.7275 of 5 stars
$28.84
-0.4%
$34.25
+18.8%
+1.4%$2.67B$6.47B14.007,600Earnings Report
Analyst Downgrade
Analyst Revision
HRMY
Harmony Biosciences
4.4663 of 5 stars
$33.48
+3.1%
$41.25
+23.2%
-25.3%$1.90B$582.02M15.79200Analyst Report
Analyst Revision
MORF
Morphic
4.5086 of 5 stars
$38.16
+7.0%
$59.75
+56.6%
-9.6%$1.91B$521,000.00-10.93115Positive News
INBX
Inhibrx
2.6129 of 5 stars
$39.56
+2.2%
$36.50
-7.7%
+53.1%$1.87B$440,000.00-9.31132Earnings Report
Upcoming Earnings
Short Interest ↓
News Coverage
Positive News
MYGN
Myriad Genetics
3.3661 of 5 stars
$23.50
+2.5%
$23.75
+1.1%
-3.1%$1.93B$678.40M-6.992,600Earnings Report
INMD
InMode
3.2336 of 5 stars
$21.99
+2.6%
$33.00
+50.1%
-33.4%$1.85B$492.05M9.56480Short Interest ↓
News Coverage
AGIO
Agios Pharmaceuticals
1.1106 of 5 stars
$34.81
+5.9%
$33.50
-3.8%
+33.3%$1.96B$26.82M-5.49389
SANA
Sana Biotechnology
1.1828 of 5 stars
$9.94
+17.6%
$9.75
-1.9%
+199.7%$1.96BN/A-6.90418Earnings Report
Analyst Report
News Coverage
Gap Up
RCUS
Arcus Biosciences
2.7512 of 5 stars
$20.18
+2.6%
$41.25
+104.4%
+8.7%$1.83B$117M-4.86500Insider Selling
EYE
National Vision
2.0481 of 5 stars
$23.11
+15.8%
$24.50
+6.0%
+2.9%$1.81B$2.01B-30.0113,975Earnings Report
Analyst Report
High Trading Volume

Related Companies and Tools

This page (NYSE:OMI) was last updated on 3/3/2024 by MarketBeat.com Staff